NVDA gained a massive 197% since our AI first added it in November - is it time to sell? 🤔Read more

Top Wall Street Forecasters Revamp Campbell Soup Expectations Ahead Of Earnings

Published 05/06/2024, 07:25
Updated 05/06/2024, 08:40
© Reuters.  Top Wall Street Forecasters Revamp Campbell Soup Expectations Ahead Of Earnings
CPB
-

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

Campbell Soup Company (NYSE:CPB) will release earnings results for its third quarter, before the opening bell on Wednesday.

Analysts expect the Camden, New Jersey-based company to report quarterly earnings at 70 cents per share. That's up from 68 cents per share in the year-ago period. Campbell Soup is projected to post quarterly revenue of $2.35 billion, according to data from Benzinga Pro.

Campbell Soup, last week, announced strategic plans to revamp its supply chain, aiming to spur business growth, improve return on invested capital, and boost the efficiency of its manufacturing and distribution network.

Campbell Soup shares fell 0.1% to close at $44.18 on Tuesday.

Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.

Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.

  • Bernstein analyst Alexia Howard upgraded the stock from Underperform to Market Perform and raised the price target from $42 to $46 on May 15. This analyst has an accuracy rate of 64%.
  • Piper Sandler analyst Michael Lavery maintained a Neutral rating with a price target of $47 on March 26. This analyst has an accuracy rate of 72%.
  • Evercore ISI Group analyst David Palmer reinstated an In-Line rating with a price target of $49 on March 13. This analyst has an accuracy rate of 68%.
  • DA Davidson analyst Brian Holland maintained a Buy rating and cut the price target from $48 to $47 on March 11. This analyst has an accuracy rate of 65%.
  • JP Morgan analyst Ken Goldman maintained a Neutral rating and cut the price target from $48 to $45 on March 6. This analyst has an accuracy rate of 80%.
Read This Next: $4M Bet On This Health Care Stock? Check Out These 3 Stocks Insiders Are Buying

Latest Ratings for CPB

DateFirmActionFromTo
Mar 2022CitigroupMaintainsNeutral
Mar 2022RBC CapitalMaintainsOutperform
Jan 2022Morgan StanleyMaintainsEqual-Weight
View More Analyst Ratings for CPB

View the Latest Analyst Ratings

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.